{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T11:23:32Z","timestamp":1788175412188,"version":"build-2803163510"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T00:00:00Z","timestamp":1784937600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004337","name":"F. Hoffmann-La Roche Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ejpb.2026.115197","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T06:57:30Z","timestamp":1784789850000},"page":"115197","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Towards a standard toolbox for compatibility testing of pediatric drug products: verification of standard vehicles for fruit juice, apple sauce, yogurt, and pudding through comparative biorelevant dissolution testing using pediatric furosemide mini-tablets"],"prefix":"10.1016","volume":"227","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7904-5409","authenticated-orcid":false,"given":"Carolin","family":"Eckert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5203-9842","authenticated-orcid":false,"given":"Cordula","family":"Stillhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonie","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7002-5833","authenticated-orcid":false,"given":"Emmanuel","family":"Scheubel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Prevot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1461-4938","authenticated-orcid":false,"given":"Marc","family":"Lindenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9164-5407","authenticated-orcid":false,"given":"Frank","family":"Karkossa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7356-5780","authenticated-orcid":false,"given":"Sandra","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2026.115197_b0005","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15041042","article-title":"Impact of tablet size and shape on the swallowability in older adults","volume":"15","author":"Hummler","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2026.115197_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121501","article-title":"Paediatric specific dosage forms: patient and formulation considerations","volume":"616","author":"Khan","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2026.115197_b0015","unstructured":"European Medicines Agency, Guideline on pharmaceutical development of medicines for paediatric use, 2013."},{"key":"10.1016\/j.ejpb.2026.115197_b0020","doi-asserted-by":"crossref","DOI":"10.1208\/s12248-020-0432-9","article-title":"Co-administration of paediatric medicines with food and drinks in the context of their physicochemical properties-a global perspective on practices and recommendations","volume":"22","author":"Martir","year":"2020","journal-title":"AAPS J."},{"key":"10.1016\/j.ejpb.2026.115197_b0025","unstructured":"Food and Drug Administration, Use of Liquids and\/or Soft Foods as Vehicles for Drug Administration: General Considerations for Selection and In Vitro Methods for Product Quality Assessments: Guidance for Industry, in: pp. 431\u2013450."},{"key":"10.1016\/j.ejpb.2026.115197_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2025.114868","article-title":"Towards the development of a standard toolbox for compatibility testing of pediatric drug products with common dosing vehicles - Fruit Juice, apple Sauce, Yogurt, and pudding","author":"Eckert","year":"2025","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2026.115197_b0035","unstructured":"Food and Drug Administration, Assessing the Effects of Food on Drugs in INDs and NDAs \u2013 Clinical Pharmacology Considerations, 2022."},{"key":"10.1016\/j.ejpb.2026.115197_b0040","unstructured":"Food and Drug Administration, Assessing the Effects of Food on Drugs in INDs and NDAs \u2013 Clinical Pharmacology Considerations, 2022."},{"key":"10.1016\/j.ejpb.2026.115197_b0045","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1208\/s12249-020-01815-9","article-title":"Impact of food and drink administration vehicles on paediatric formulation performance part 2: dissolution of montelukast sodium and mesalazine formulations","volume":"21","author":"Martir","year":"2020","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejpb.2026.115197_b0050","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.xphs.2021.05.003","article-title":"A toolbox for mimicking gastrointestinal conditions in children: simulated paediatric breakfast media (SPBM) for addressing the variability of gastric contents after typical paediatric breakfasts","volume":"111","author":"Freerks","year":"2022","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2026.115197_b0055","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s11095-020-02912-x","article-title":"A biopredictive in vitro approach for assessing compatibility of a novel pediatric hydrocortisone drug product within common pediatric dosing vehicles","volume":"37","author":"Wollmer","year":"2020","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2026.115197_b0060","doi-asserted-by":"crossref","DOI":"10.1007\/s11095-022-03208-y","article-title":"Vehicles for drug administration to children: results and learnings from an in-depth screening of FDA-recommended liquids and soft foods for product quality assessment","volume":"39","author":"Freerks","year":"2022","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2026.115197_b0065","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1208\/s12249-020-01722-z","article-title":"Impact of food and drink administration vehicles on paediatric formulation performance: part 1\u2014effects on solubility of poorly soluble drugs","volume":"21","author":"Martir","year":"2020","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejpb.2026.115197_b0070","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejpb.2020.08.014","article-title":"Safe, swallowable and palatable paediatric mini-tablet formulations for a WHO model list of essential medicines for children compound - a promising starting point for future PUMA applications","volume":"156","author":"Freerks","year":"2020","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2026.115197_b0075","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/jphp.12365","article-title":"Prediction of in vivo pharmacokinetic profile for immediate and modified release oral dosage forms of furosemide using an in-vitro-in-silico-in-vivo approach","volume":"67","author":"Otsuka","year":"2014","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejpb.2026.115197_b0080","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1021\/ac9810563","article-title":"Hydrophobicity of ionizable compounds. A theoretical study and measurements of diuretic octanol\u2212water partition coefficients by countercurrent chromatography","volume":"71","author":"Berthod","year":"1999","journal-title":"Anal. Chem."},{"key":"10.1016\/j.ejpb.2026.115197_b0085","unstructured":"PubChem, Hazardous Substances Data Bank (HSDB) 3086 Furosemide, 2024, https:\/\/pubchem.ncbi.nlm.nih.gov\/source\/hsdb\/3086#section=Interactions-%28Complete%29, accessed 25 April 2024."},{"key":"10.1016\/j.ejpb.2026.115197_b0090","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1208\/s12249-016-0671-3","article-title":"Simulating different dosing scenarios for a child-appropriate valproate ER formulation in a new pediatric two-stage dissolution model","volume":"18","author":"Karkossa","year":"2017","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejpb.2026.115197_b0095","unstructured":"World Health Organization, WHO Child Growth Standards: Interpreting Growth Indicators, 2006, https:\/\/www.who.int\/toolkits\/child-growth-standards, accessed 19 April 2024."},{"key":"10.1016\/j.ejpb.2026.115197_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.114084","article-title":"Review of paediatric gastrointestinal physiology relevant to the absorption of orally administered medicines","volume":"181","author":"Wollmer","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2026.115197_b0105","doi-asserted-by":"crossref","first-page":"799","DOI":"10.3109\/00365529209011187","article-title":"Gastric emptying in infants with gastroesophageal reflux. Ultrasound evaluation before and after cisapride administration","volume":"27","author":"Carroccio","year":"1992","journal-title":"Scand. J. Gastroenterol."},{"issue":"1996","key":"10.1016\/j.ejpb.2026.115197_b0110","first-page":"1112","article-title":"Gastric emptying in pre-term infants: the effect of breast milk fortifier","volume":"85","author":"Ewer","year":"1992","journal-title":"Acta Paediatr. (Oslo, Norway)"},{"key":"10.1016\/j.ejpb.2026.115197_b0115","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1111\/jphp.12777","article-title":"Assessing the influence of media composition and ionic strength on drug release from commercial immediate-release and enteric-coated aspirin tablets","volume":"69","author":"Karkossa","year":"2017","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejpb.2026.115197_b0120","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ejps.2013.09.020","article-title":"A dynamic system for the simulation of fasting luminal pH-gradients using hydrogen carbonate buffers for dissolution testing of ionisable compounds","volume":"51","author":"Garbacz","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2026.115197_b0125","first-page":"234","article-title":"Fractional factorial design, Wiley Interdisciplinary Reviews","volume":"1","author":"Gunst","year":"2009","journal-title":"Comput. Stat."},{"key":"10.1016\/j.ejpb.2026.115197_b0130","unstructured":"Stat-Ease, Inc., Stat-Ease 360, 2022."},{"key":"10.1016\/j.ejpb.2026.115197_b0135","unstructured":"DATAtab Team, DATAtab: Online Statistics Calculator, DATAtab e.U., Graz, Austria, 2024."},{"key":"10.1016\/j.ejpb.2026.115197_b0140","unstructured":"World Health Organization, Model List of Essential Medicines for Children - 9th list, 2023, 2023, https:\/\/www.who.int\/publications\/i\/item\/WHO-MHP-HPS-EML-2023.03, accessed 23 April 2024."},{"key":"10.1016\/j.ejpb.2026.115197_b0145","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1023\/A:1016212804288","article-title":"A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability","volume":"12","author":"Amidon","year":"1995","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2026.115197_b0150","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12121175","article-title":"BCS class IV oral drugs and absorption windows: regional-dependent intestinal permeability of furosemide","volume":"12","author":"Markovic","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2026.115197_b0155","first-page":"2544","article-title":"Biowaiver monographs for immediate release solid oral dosage forms: furosemide","volume":"99","author":"Granero","year":"2010","journal-title":"JPharmSci"},{"key":"10.1016\/j.ejpb.2026.115197_b0160","first-page":"304","article-title":"Some aspects of the photochemical degradation of frusemide","volume":"51","author":"Rwobotham","year":"1976","journal-title":"Pharmaceutica Acta Helvetiae"},{"key":"10.1016\/j.ejpb.2026.115197_b0165","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ijpharm.2007.05.039","article-title":"Effect of pH on the solubility and release of furosemide from polyamidoamine (PAMAM) dendrimer complexes","volume":"345","author":"Devarakonda","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2026.115197_b0170","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0378-5173(02)00586-0","article-title":"Physicochemical characterization of solid dispersion of furosemide with TPGS","volume":"251","author":"Shin","year":"2003","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2026.115197_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.122737","article-title":"The effect of food vehicles on in vitro performance of pantoprazole sodium delayed release sprinkle formulation","volume":"635","author":"Wu","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2026.115197_b0180","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1208\/s12248-010-9203-3","article-title":"The use of biorelevant dissolution media to forecast the in vivo performance of a drug","volume":"12","author":"Klein","year":"2010","journal-title":"AAPS J."},{"key":"10.1016\/j.ejpb.2026.115197_b0185","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1211\/0022357023367","article-title":"Media to simulate the postprandial stomach I. Matching the physicochemical characteristics of standard breakfasts","volume":"56","author":"Klein","year":"2004","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejpb.2026.115197_b0190","first-page":"45","article-title":"Influence of food and sex on the pharmacokinetics and pharmacodynamics of furosemide","volume":"20","author":"Magallanes","year":"2016","journal-title":"Curr. Top. Pharmacol."},{"key":"10.1016\/j.ejpb.2026.115197_b0195","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1046\/j.1365-2125.1996.00494.x","article-title":"Effect of food on the absorption of frusemide and bumetanide in man","volume":"42","author":"McCrindle","year":"1996","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejpb.2026.115197_b0200","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/BF00615967","article-title":"Reduced bioavailability and effect of furosemide given with food","volume":"29","author":"Beermann","year":"1986","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejpb.2026.115197_b0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10601330701220520","article-title":"Design of experiments: concept and applications of Plackett Burman design","volume":"24","author":"Vanaja","year":"2007","journal-title":"Clin. Res. Regulat. Affairs"},{"key":"10.1016\/j.ejpb.2026.115197_b0210","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ijggc.2013.12.007","article-title":"Model complexity in carbon sequestration: a design of experiment and response surface uncertainty analysis","volume":"22","author":"Li","year":"2014","journal-title":"Int. J. Greenhouse Gas Control"},{"key":"10.1016\/j.ejpb.2026.115197_b0215","first-page":"207","article-title":"Crushed tablets: does the administration of food vehicles and thickened fluids to aid medication swallowing alter drug release?","volume":"17","author":"Manrique","year":"2014","journal-title":"J. Pharm. Sci."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641126002183?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641126002183?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T11:11:35Z","timestamp":1788174695000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641126002183"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":43,"alternative-id":["S0939641126002183"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2026.115197","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Towards a standard toolbox for compatibility testing of pediatric drug products: verification of standard vehicles for fruit juice, apple sauce, yogurt, and pudding through comparative biorelevant dissolution testing using pediatric furosemide mini-tablets","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2026.115197","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115197"}}